First Patient Dosed in EO2401 Clinical Trial for Adrenal Tumors
source: pixabay.com

First Patient Dosed in EO2401 Clinical Trial for Adrenal Tumors

Early this week, clinical-stage biopharmaceutical company Enterome announced that the first patient was dosed in a Phase 1/2 clinical trial. The SPENCER trial will evaluate EO2401 as a potential treatment…

Continue Reading First Patient Dosed in EO2401 Clinical Trial for Adrenal Tumors
September 13-19 is Mitochondrial Disease Awareness Week: Spreading Rare Disease Awareness
source: pixabay.com

September 13-19 is Mitochondrial Disease Awareness Week: Spreading Rare Disease Awareness

The third week of September is recognized annually as Mitochondrial Disease Awareness Week. This global event is held in order to increase awareness of mitochondrial disease in the medical community…

Continue Reading September 13-19 is Mitochondrial Disease Awareness Week: Spreading Rare Disease Awareness
ICYMI: She Was Told She Was Depressed. A Decade Later, She Found Out She Had Lyme Disease
source: pixabay.com

ICYMI: She Was Told She Was Depressed. A Decade Later, She Found Out She Had Lyme Disease

A rare disease patient's medical odyssey often begins with a search. Rhisa Perera wrote a narrative in lymedisease.org about her long journey navigating the medical world to find answers and…

Continue Reading ICYMI: She Was Told She Was Depressed. A Decade Later, She Found Out She Had Lyme Disease
September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
source: pixabay.com

September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness

This year, September 13-19 is being recognized as Balance Awareness Week. Organized by the Vestibular Disorders Association, the goal of this campaign is to help spread awareness among both the…

Continue Reading September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
Study Says Asian Patients With NAFLD Have Lower Risk of Cirrhosis
https://pixabay.com/illustrations/scale-weigh-in-mass-weight-scales-1133910/

Study Says Asian Patients With NAFLD Have Lower Risk of Cirrhosis

This past week, Target RWE announced data from its TARGET-NASH study, designed to better understand differences in health outcomes for patients with nonalcoholic fatty liver disease (NAFLD). According to their…

Continue Reading Study Says Asian Patients With NAFLD Have Lower Risk of Cirrhosis
Close Menu